$ICMB Balance Sheet | Understand Stock

$ICMB

$0.75 +$0.00 (0.07%) Close

$ICMB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022
Assets
Non-controlled, non-affiliated investments, at fair value (amortized cost of $225,962,819 and $219,319,251, respectively)
Investments, at fair value
Investment, Unaffiliated Issuer
Investment, Affiliated Issuer, Noncontrolled
Non-Controlled, Non-Affiliated Investments
Non-Controlled, Affiliated Investments
Affiliate Investments
Total investments, at fair value
Investments, at fair value (amortized cost of $249,903,799 and $243,298,816, respectively)
Non-Controlled, Non-Affiliated Investments
Affiliate Investments
Total investments, at fair value (amortized cost of $249,903,799 and $243,298,816, respectively)

Cash and cash equivalents
Restricted cash and cash equivalents
Receivable for investments sold
Principal receivable
Interest receivable
Payment-in-kind interest receivable
Due from affiliate
Long-term receivable
Escrow receivable
Total amount due from affiliate
Short-term receivable
Prepaid expenses and other assets
Total Assets
Liabilities
Debt:
Revolving credit facility
Notes payable
2029 Notes payable
2026 Notes payable
Total notes payable
Deferred debt issuance costs
Unamortized discount
Debt, net
Interest payable
Dividend payable
Payable for investments purchased
Base management fees payable
Income-based incentive fees payable
Deferred income liability
Directors' fees payable
Accrued expenses and other liabilities
Total Liabilities
Net Assets
Common stock, par value $0.001 per share (100,000,000 shares authorized and 14,432,472 and 14,432,472 shares issued and outstanding, respectively)
Additional paid-in capital
Distributable earnings (loss)
Total Net Assets
Total Liabilities and Net Assets
Net Asset Value Per Share

Comments